Annexon outlines Q4 BLA filing for tanruprubart while adding month 24 dual primary endpoint to ARCHER II — See source for full details.
$ANNX
Price history, market instrument context, member research, and related headlines in one place.
ANNX key statistics
NasdaqGSUSD
52-week range
$2.5423%$7.18
Latest session $3.51–$3.82Annexon, Inc. (ANNX) is a stock instrument quoted on NasdaqGS in USD. The most recently published price is $3.60, down $0.07 (1.91%) from the previous close of $3.67. It has traded between $3.51 and $3.82 in the latest session. Over the past year it has ranged from $2.54 to $7.18, leaving it in the lower quarter of its 52-week range (23%). Reported volume for the session was 2.6M. Figures are the latest published by the exchange feed and are not a recommendation.
Primary market bars from Yahoo Finance · Extended-hours prints appear when supplied by the venue · Interactive charts powered by TradingView Lightweight Charts™ · Not a recommendation
Source-linked intelligence
Related news
Annexon Biosciences GAAP EPS of -$0.28 misses by $0.04 — See source for full details.
Annexon adds month 24 endpoint to phase 3 dry AMD trial — See source for full details.
Loading $ANNX research…